Hanna K Sanoff (Hanna Sanoff)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Clostridium Difficile

Lymph Node Metastasis

Metastatic Colorectal Cancer

Top Venues

JCO oncology practice

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan D Sorah, Allision M Deal, Sophia I Stein, Mattias Jonsson, Federico Innocenti, Anita Turk, Jeremiah C Boles, William Irvin, Ethan M Basch, Hanna K Sanoff, William A Wood
Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance. The oncologist (2024)
Hanna K Sanoff, Allision M Deal, Jai Patel, Jonathan D Sorah, Jacquelyne Gaddy, Bert O'Neil, Anita A Turk, William Irvin, Jeremiah Boles, Michael S Lee, Autumn McRee, Alexis C Wardell, Karen E Weck, Ethan M Basch, William A Wood, Federico Innocenti
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer. The oncologist (2024)
Hanna K Sanoff, Allision M Deal, Jai Patel, Jonathan D Sorah, Jacquelyne Gaddy, Bert O'Neil, Anita A Turk, William Irvin, Jeremiah Boles, Michael S Lee, Autumn McRee, Alexis C Wardell, Karen E Weck, Ethan M Basch, William A Wood, Federico Innocenti
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer. The oncologist (2024)
Hanna K Sanoff
Putting IDEA's Results Into Practice: Practicality Should Rule Complexity in Stage III Colon Cancer. JCO oncology practice (2024)
Christine D Hsu, Louise M Henderson, Bradford E Jackson, Christopher D Baggett, Michele Jonsson Funk, Andrew F Olshan, Parul Gupta, Alfred Sidney Barritt, Hanna K Sanoff, Stephanie B Wheeler, Andrew M Moon, Jennifer L Lund
Hepatocellular Carcinoma Surveillance Among Individuals with Cirrhosis: Trends by Payer, Etiology and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Jacob Newton Stein, Lisette Dunham, William A Wood, Emily M Ray, Hanna K Sanoff, Jennifer Elston Lafata
Predicting Acute Care Events Among Patients Initiating Chemotherapy: A Practice-Based Validation and Adaptation of the PROACCT Model. JCO oncology practice (2023)
Christine D Hsu, Louise M Henderson, Bradford E Jackson, Christopher D Baggett, Michele Jonsson Funk, Andrew F Olshan, Parul Gupta, Alfred Sidney Barritt, Hanna K Sanoff, Stephanie B Wheeler, Andrew M Moon, Jennifer L Lund
Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010-2018. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Van Karlyle Morris, Erin B Kennedy, Nancy N Baxter, Al Bowen Benson, Andrea Cercek, May Cho, Kristen K Ciombor, Chiara Cremolini, Anjee Davis, Dustin A Deming, Marwan G Fakih, Sepideh Gholami, Theodore S Hong, Ishmael Jaiyesimi, Kelsey A Klute, Christopher H Lieu, Hanna K Sanoff, John H Strickler, Sarah White, Jason A Willis, Cathy Eng
Treatment of Metastatic Colorectal Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tomohiro F Nishijima, Allison M Deal, Grant R Williams, Hanna K Sanoff, Kirsten A Nyrop, Hyman B Muss
Impact of the Cancer and Aging Research Group score and treatment intensity on survival and toxicity outcomes in older adults with advanced noncolorectal gastrointestinal cancers. Cancer 128 (10) (2022)
Chelsea K Osterman, Hanna K Sanoff, William A Wood, Megan Fasold, Jennifer Elston Lafata
Predictive Modeling for Adverse Events and Risk Stratification Programs for People Receiving Cancer Treatment. JCO oncology practice (2021)
Richard D Kim, Hanna K Sanoff, Andrew S Poklepovic, Heloisa Soares, Jongphil Kim, Jing Lyu, Yingmiao Liu, Andrew B Nixon, Dae Won Kim
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer. Cancer 126 (15) (2020)
Hanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, Seamus O'Reilly, Samer S Kasbari, Richard D Kim, Ray McDermott, Dominic T Moore, William Zamboni, William Grogan, Allen Lee Cohn, Tanios S Bekaii-Saab, Gregory Leonard, Theresa Ryan, Olugbenga O Olowokure, Nishan H Fernando, John McCaffrey, Bassel F El-Rayes, Anne M Horgan, Gary Bradley Sherrill, George Hosni Yacoub, Bert H O'Neil
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer. Cancer 124 (15) (2018)
Hanna K Sanoff, YunKyung Chang, Jennifer L Lund, Bert H O'Neil, Stacie B Dusetzina
Immortal time bias or sorafenib effect in elderly patients with HCC? Hepatology (Baltimore, Md.) 66 (2) (2017)
Grant R Williams, Allison M Deal, Jennifer L Lund, YunKyung Chang, Hyman B Muss, Mackenzi Pergolotti, Emily J Guerard, Shlomit Strulov Shachar, Yue Wang, Kelly Kenzik, Hanna K Sanoff
Patient-Reported Comorbidity and Survival in Older Adults with Cancer. The oncologist 23 (4) (2017)